Results 71 to 80 of about 48,507 (298)

TPO receptor agonist for chronic idiopathic thrombocytopenic purpura.

open access: yesCochrane Database of Systematic Reviews, 2011
BACKGROUND Chronic idiopathic thrombocytopenic purpura (ITP) is an acquired autoimmune disorder that is characterized predominantly by a low platelet count.
Yan Zeng, Xin Duan, Jia-jun Xu, X. Ni
semanticscholar   +1 more source

Origins of T‐cell‐mediated autoimmunity in acquired aplastic anaemia

open access: yesBritish Journal of Haematology, Volume 206, Issue 4, Page 1035-1053, April 2025.
Acquired aplastic anaemia (AA) is an autoimmune bone marrow failure disease caused by a cytotoxic T‐cell–mediated attack on haematopoietic stem and progenitor cells (HSPCs). Despite significant progress in understanding T‐cell repertoire alterations in AA, the identification of specific pathogenic T cells remains elusive.
Aura Enache   +2 more
wiley   +1 more source

High-dose Dexamethasone Therapy as the Initial Treatment for Idiopathic Thrombocytopenic Purpura: Protocol for a Multicenter, Open-label, Single Arm Trial [PDF]

open access: yes, 2018
Standard therapy for idiopathic thrombocytopenic purpura (ITP) has not been established. We are conducting a multicenter, prospective trial to determine the efficacy and safety of short-term, high-dose dexamethasone therapy in ITP patients aged 18-80 ...
Hidaka, Michihiro   +19 more
core   +1 more source

A Case Associated with Comorbidities Among Cerebral Infarction, Idiopathic Thrombocytopenic Purpura, and Triple X Syndrome

open access: yesTurkish Journal of Hematology, 2014
A 46-year-old female presented to the emergency room due to the chief complaint of left-sided weakness. By imaging study, she was diagnosed with cerebral infarction.
Hanjun Kim   +5 more
doaj   +1 more source

IDIOPATHIC THROMBOCYTOPENIC PURPURA [PDF]

open access: yesINDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY, 2018
Idiopathic thrombocytopenic purpura is an autoimunne disease with low platelet count and bleeding manifestation like purpura, echymosis, petechie, mucosa membrane bleeding. The cause of ITP is platelet coated with specific thrombocyte autoantibody. Idiopathicthrombocytopenic purpura is classified as primary or secondary.
Diana Aulia, Alvina
openaire   +2 more sources

A New Diagnostic Approach for Myelodysplastic Neoplasms Using a Combination of Scores Based on Flow Cytometry and Automated Hematology Sysmex XN Analyzers

open access: yesInternational Journal of Laboratory Hematology, Volume 47, Issue 2, Page 236-245, April 2025.
ABSTRACT Introduction The first‐step in diagnosis of myelodysplastic neoplasms (MDS) is essentially based on bone marrow cytomorphology. However, cytomorphology of MDS is often a difficult exercise, subject to inter‐operator variability. Our study aims to evaluate whether the combination of two dysplasia scores, the extended Ogata score and the MDS‐CBC
Ludovic Firrera   +6 more
wiley   +1 more source

Childhood Idiopathic Thrombocytopenic Purpura: A Retrospective Analysis Of Clinical Features And Response To Treatment

open access: yesمجلة كلية الطب, 2006
Background : A retrospective study was done in the Pediatric ward /AL-Kadhimiyia Teaching Hospital on cases diagnosed as idiopathic thrombocytopenic Purpura admitted since the first of January1992 – the end of December 2004.
Sawsan S. Abbas
doaj  

CAUSES OF DEVELOPMENT OF ACUTE AND CHRONIC THROMBOCYTOPENIA IN CHILDREN OF IRKUTSK REGION

open access: yesActa Biomedica Scientifica, 2018
Background. Immune thrombocytopenia in children is not a rare disease. Currently, this diagnosis is found in 2 times more often than 5-10 years ago. Acute immune thrombocytopenia is increasingly taking on a chronic course. Aims.
N. N. Martynovich   +2 more
doaj   +1 more source

The European Medicines Agency review of eltrombopag (Revolade) for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura: summary of the scientific assessment of the Committee for Medicinal Products for Human Use

open access: yesHaematologica, 2011
On 11th March 2010, the European Commission issued a marketing authorization valid throughout the European Union for Revolade for the treatment of adult chronic immune (idiopathic) thrombocytopenic purpura.
Maria Nieto   +10 more
semanticscholar   +1 more source

A Systematic Review of Vascular Injuries: A Review of Petechiae, Purpura, and Ecchymosis in Critical Situations Following COVID‐19 Vaccination

open access: yesHealth Science Reports, Volume 8, Issue 3, March 2025.
ABSTRACT Background and Aims Vascular injuries characterized by petechiae, purpura, and ecchymosis have been reported as potential adverse effects following COVID‐19 vaccination. This study aims to identify the characteristics of patients experiencing vascular injuries postvaccination and to outline key clinical considerations.
Yasamin Kalantari   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy